Shake up in Caliper boardroom
A number of senior executives at microfluidics and lab automation specialist Caliper Technologies are leaving the company in a reorganisation aimed at cutting costs and breaking even in cash flow terms in 2005.
A number of senior executives at microfluidics and lab automation specialist Caliper Technologies are leaving the company in a reorganisation aimed at cutting costs and breaking even in cash flow terms in 2005.
General Electric was yesterday cleared to press ahead with its €8.1 billion acquisition of UK Amersham by the US antitrust authorities, and promptly announced a sweeping reorganisation of the business in an attempt to boost its profit growth.
De Novo Pharmaceuticals says it has refocused its business from in-house drug discovery to commercialisation of its proprietary in silico drug discovery platforms, halving its workforce in the process.
German biotech company flyion has developed a new technology which speeds up drug development and could reduce the number of animals needed in research.
Israeli generic pharmaceutical company Taro Pharmaceutical Industries has been granted a US patent for a means of dosing liquid medicines into a spoon without any spillages.
The worldwide cellular assays market is projected to grow by more than 50 per cent to $700 million over the next five years as pharmaceutical and biotechnology companies seek methods to increase the efficiency of their drug discovery efforts,...
French company Kalix has launched a new system called the Universal Feeder which increases the production capacity of its machines for filling and cartoning pharmaceuticals and cosmetics in tubes.